EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtÜbersichtsarbeit

Impact of Phenotype on Recurrence of VT Post‐Ablation in Patients With Nonischemic Cardiomyopathy

Shreyas Singireddy, Sami Shoura, Darshine Venugopal, Christopher Chinnatambi, Siddharth Shah, Christopher Sparrow, Timir Baman, Amit Mehrotra

Pacing and Clinical Electrophysiology · 2026-11 · 49 (11) · 1676-1684

DOI: 10.1111/pace.70340 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Pacing and Clinical Electrophysiology, online erschienen am 26.06.2026. Verfasst von Shreyas Singireddy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, University of Illinois College of Medicine, Peoria, Illinois, USA. Hauptthemen laut MEDLINE: Cardiomyopathies, Catheter Ablation, Tachycardia, Ventricular. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ventricular tachycardia (VT) ablation outcomes in nonischemic cardiomyopathy (NICM) may differ by disease phenotype, but prior studies have pooled NICM as a single entity. We performed a phenotype‐stratified meta‐analysis of VT ablation outcomes across six major NICM subtypes.

Methods

We systematically searched PubMed, Embase, and the Cochrane Library through January 2026. Studies were stratified by phenotype: lamin A/C (LMNA), cardiac sarcoidosis, dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), myocarditis, and arrhythmogenic right ventricular cardiomyopathy (ARVC). The primary outcome was VT recurrence. Proportions were pooled using restricted maximum likelihood estimation on the logit scale. Phenotype differences were tested via mixed‐effects meta‐regression.

Results

Eighteen studies (1699 patients) met inclusion criteria after rigorous center‐level overlap resolution. VT recurrence differed significantly across phenotypes (F [5,12] = 3.78, p = 0.027). LMNA had the highest recurrence (82.6%; 95% CI 51.6%–95.5%; k = 5), followed by sarcoidosis (57.1%; 32.2%–78.8%; k = 2), DCM (42.7%; 24.1%–63.6%; k = 4), HCM (36.2%; 23.8%–50.7%; k = 2), myocarditis (34.5%; 27.3%–42.5%; k = 2), and ARVC (33.8%; 16.0%–57.9%; k = 3). Phenotype explained 44.7% of between‐study heterogeneity.

Conclusions

VT ablation outcomes in NICM varied by the underlying disease phenotype, with recurrence rates ranging from 82.6% in LMNA cardiomyopathy to 33.8% in ARVC. These hypothesis‐generating findings argue against treating NICM as a unified category and provide a foundation for phenotype‐specific procedural counseling and clinical trial stratification that warrants validation in prospective registries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesCatheter AblationTachycardia, VentricularHumansRecurrencePhenotype

Stichwörter der Autor:innen

arrhythmogenic right ventricular cardiomyopathycatheter ablationlamin A/Cmeta‐analysisnonischemic cardiomyopathysarcoidosisventricular tachycardia

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, University of Illinois College of Medicine, Peoria, Illinois, USA.
  • Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, Georgia, USA.

Zitieren

APA

Singireddy, S., Shoura, S., Venugopal, D., Chinnatambi, C., Shah, S., Sparrow, C., Baman, T., & Mehrotra, A. (2026). Impact of Phenotype on Recurrence of VT Post‐Ablation in Patients With Nonischemic Cardiomyopathy. Pacing and Clinical Electrophysiology, 49(11), 1676-1684. https://doi.org/10.1111/pace.70340

Vancouver

Singireddy S, Shoura S, Venugopal D, Chinnatambi C, Shah S, Sparrow C, et al. Impact of Phenotype on Recurrence of VT Post‐Ablation in Patients With Nonischemic Cardiomyopathy. Pacing and Clinical Electrophysiology. 2026;49(11):1676-1684. doi:10.1111/pace.70340

BibTeX
@article{Singireddy2026,
  author = {Singireddy, Shreyas and Shoura, Sami and Venugopal, Darshine and Chinnatambi, Christopher and Shah, Siddharth and Sparrow, Christopher and Baman, Timir and Mehrotra, Amit},
  title = {Impact of Phenotype on Recurrence of VT Post‐Ablation in Patients With Nonischemic Cardiomyopathy},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  volume = {49},
  number = {11},
  pages = {1676--1684},
  doi = {10.1111/pace.70340}
}
Kostenlos starten →